TickerGuard
Buy Day today: Neutral (58) Mixed market breadth · no major macro event
TNGX

Tango Therapeutics Inc

Healthcare · Biotechnology · —

23.10$ -0.7% vs. previous close Closing price · As of: Oct 5, 2026

Statements

Income Statement

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement TNGX
Line item 2019 2020 2021 2022 2023 2024 2025
– -68.9% +383.8% -32.9% +46.9% +15.2% +48.3%
– -95.0% +21.0% +104.9% +2,759.9% -97.8% -8.7%
– – +514.2% -32.9% +46.9% +15.2% +42.9%
– +54.9% +55.3% +36.4% +8.8% +24.9% -8.2%
– +30.9% +78.4% +70.6% +18.2% +23.2% -5.1%
– +672.6% +63.5% +42.7% +10.9% +24.5% -8.7%
– – – – – – –
– – – +157.8% – – –
– – – – – – –
– – – -81.5% +148.1% +55.2% -98.1%
– – – – – – –
– – – – – – –

Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?